Page last updated: 2024-08-21

copper gluconate and Joint Diseases

copper gluconate has been researched along with Joint Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooke, DA; Donovan, KL; Fisher, DJ; White, AD1
Andujar, J; Ballou, WR; Berman, JD; Chulay, JD; Gordon, DM; McClain, JB; Shanks, GD1

Trials

1 trial(s) available for copper gluconate and Joint Diseases

ArticleYear
Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis.
    Lancet (London, England), 1987, Jul-04, Volume: 2, Issue:8549

    Topics: Adolescent; Adult; Antimony Sodium Gluconate; Clinical Trials as Topic; Double-Blind Method; Follow-Up Studies; Gluconates; Humans; Joint Diseases; Leishmania braziliensis; Leishmania donovani; Leishmaniasis; Male; Military Personnel; Random Allocation; Safety

1987

Other Studies

1 other study(ies) available for copper gluconate and Joint Diseases

ArticleYear
Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant recipient.
    The Journal of infection, 1990, Volume: 21, Issue:1

    Topics: Adult; Animals; Antimony Sodium Gluconate; Cyclosporins; Gluconates; Humans; Immune Tolerance; Joint Diseases; Leishmania donovani; Leishmaniasis, Visceral; Male; Malta; Pancreatitis

1990